{"id":2236,"date":"2018-12-15T05:08:22","date_gmt":"2018-12-14T20:08:22","guid":{"rendered":"http:\/\/spera.rdy.jp\/?page_id=2236"},"modified":"2025-12-15T18:02:26","modified_gmt":"2025-12-15T09:02:26","slug":"outline","status":"publish","type":"page","link":"https:\/\/heuristic-ardinghelli.153-122-123-210.plesk.page\/en\/company\/outline\/","title":{"rendered":"Company Outline"},"content":{"rendered":"\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Company Name<\/th>\nSPERA PHARMA, Inc.<\/td>\n<\/tr>\n
Representative<\/th>\nKeitaro Iwaki, President & Representative Director<\/td>\n<\/tr>\n
Establishment<\/th>\nApr, 2017<\/td>\n<\/tr>\n
Business Started<\/th>\nJuly, 2017<\/td>\n<\/tr>\n
Paid in Capital<\/th>\n310 million yen<\/td>\n<\/tr>\n
Shareholder<\/th>\nAstena Holdings Co., Ltd.<\/a> 100%<\/td>\n<\/tr>\n
Address<\/th>\n17-85 Jusohonmachi 2-chome, Yodogawa-ku, Osaka 532-0024, Japan<\/td>\n<\/tr>\n
TEL<\/th>\n+81-6-7653-6818<\/td>\n<\/tr>\n
Business<\/th>\nPharmaceuticals Contract R&D and Manufacturing<\/td>\n<\/tr>\n
Number of Employees<\/th>\n249 (As of December 1, 2025)<\/td>\n<\/tr>\n
Directors<\/th>\n\nKeitaro Iwaki, President & Representative Director<\/br>
\nHirotoshi Naruse, Director<\/br>
\nRami Suzuki, Outside Director\n<\/td>\n<\/tr>\n
Auditor<\/th>\nToshimitsu Isobe, Audit & Supervisory Board Member<\/td>\n<\/tr>\n
Affiliated Companies<\/th>\nSPERA NEXUS, Inc.<\/a><\/br>
\nJITSUBO Co., Ltd.<\/a><\/br>IWAKI SEIYAKU SAKURA FACTORY CO., LTD.<\/a>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Access<\/h4>\n
\n